Clinical Trials in Boston

Showing 6321-6340 of 17,836 trials

Suvorexant on Sleep Disturbance in Patients With Chronic Insomnia and Suboptimally Controlled Type 2 Diabetes

NCT03818581

The investigators aim to determine the effect of suvorexant on subjective total sleep time (TST) in suboptimally controlled Type 2 diabetics with chronic insomnia in a randomized placebo-controlled trial for 3 months.

Type 2 Diabetes MellitusInsomniaSleep Disorder+1 more

Massachusetts General Hospital108 participantsStarted Mar 2019

Boston, Massachusetts, United States

TERMINATEDPhase 1< 1 mile

Assess Safety and Tolerability of ART-123 + FOLFOX + Bevacizumab in Metastatic Colorectal Cancer Patients

NCT05251727

To evaluate the safety and tolerability of ART-123 in patients with metastatic colorectal cancer who receive oxaliplatin-containing chemotherapy and bevacizumab

Chemotherapy-induced Peripheral Neuropathy

Veloxis Pharmaceuticals77 participantsStarted Mar 2022

Beverly Hills, California, United States • Los Angeles, California, United States • Norwich, Connecticut, United States +29 more locations

Suvorexant on Sleep Disturbance in Patients With Chronic Insomnia and Suboptimally Controlled Type 2 Diabetes

Assess Safety and Tolerability of ART-123 + FOLFOX + Bevacizumab in Metastatic Colorectal Cancer Patients

Find Trials by Condition in Boston

Physiologic Pacing Registry

Uproleselan With Pre-Transplant Conditioning in Hematopoietic Stem Cell Transplantation for AML

Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease)

EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial)

Evaluation of Kisspeptin Stimulated Insulin Secretion With Hyperglycemic Clamp

Development and Implementation of Electronic Decision Aids for Genetic Testing in Inherited Cancer Syndromes

Levari Exp.20: 2D - Partial Feedback

Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children

A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations

Optimal Treatment of Veterans With PTSD and Comorbid OUD

Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast Cancer

tDCS Plus Virtual Reality for PTSD

Web-based Muscle-strengthening and Aerobic Physical Activity Intervention for Latinas

A Research Study of How Well Macimorelin Works to Find Out if Children Have a Lack of Growth Hormone and How Safe it is

A Study to Evaluate the Safety and Efficacy of JCAR017 in Pediatric Subjects With Relapsed/Refractory (r/r) B-cell Acute Lymphoblastic Leukemia (B-ALL) and B-cell Non-Hodgkin Lymphoma (B-NHL)

Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis

HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

ROX Index for the Timing of Intubation in Nasal High Flow